Associate
Powers Pyles Sutter and Verville PC
Mark Ogunsusi is an associate in the Drug Pricing and 340B Program practice group of Powers Pyles Sutter & Verville, focusing his practice primarily on regulatory matters involving pharmaceutical pricing and the 340B federal drug discount program. In addition to his legal degree, Mark is a doctor of pharmacy. Mark regularly advises an array of healthcare entities on the nuances of the 340B program, the Medicaid drug rebate program, federal pharmacy law, food and drug law, and state pharmacy law. Mark has significant experience in all aspects of the 340B program, including covered entity registrations, contract pharmacy arrangements, patient eligibility determinations, duplicate discount issues, drug inventory management, eligibility requirements, third-party vendor arrangements, auditable records requirements, and other 340B program compliance matters. He has over ten years of experience as a pharmacist, which informs his health law practice. His other relevant prior experience includes serving as the CEO of PrystM LLC, a healthcare and technology consulting firm. Mark is a co-author of "340B Drug Pricing Program," a chapter in the Health Care Compliance Association's 2021 Complete Healthcare Compliance Manual. Mark earned his J.D. from Georgetown University Law Center and graduated with a doctorate of pharmacy from Mercer University College of Pharmacy.
PSaA1 - The New and Changing 340B Landscape: Legislative, Litigation, and Policy Updates
Saturday, February 8, 2025
8:00 AM – 9:15 AM ET